Scholarlink

<p>NKD1 is a known suppressor of the Wnt/β-catenin pathway. However, our previous study revealed that NKD1 could promote the proliferation and migration of colon cancer cells, enhancing colon cancer progression via unknown mechanisms. In the present study, we found that peroxisome proliferator-activated receptor δ (PPARδ) is a transcription factor of the NKD1 gene. By analyzing the differential protein expression profiles between SW620 and SW620-nkd1<sup>−/−</sup> cells, we found that NKD1 dramatically increased MYC protein expression. Further study revealed that the MYC protein was degraded mainly through the autophagy pathway in colon cancer cells and that NKD1 restrained this process by suppressing the interaction between LC3B and MYC proteins. Interestingly, we found that NKD1 inhibited the autophagy signaling pathway. In-depth research revealed that NKD1 bound to the MYC protein through the EF-hand domain, facilitating the entry of the MYC protein into the nucleus and inhibiting cell apoptosis. Moreover, NKD1 activated the expression of MYC downstream target genes through MYC. Functionally, the PPARδ/NKD1/MYC signaling pathway increased colon cancer cells’ proliferation, migration and angiogenesis capabilities. Therefore, NKD1 may serve as a specific biomarker for colon cancer and a potential new target for tumor treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

NKD1 enhances colon cancer progression by inhibiting the autophagic degradation of MYC

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月17日

查看全文
  • Wenbin Lu,
  • Jianjun Tang,
  • Yue Wang,
  • Xiaoyan Gu,
  • Hua Zhang,
  • Yungang Liu,
  • Ying Xiao,
  • Qi Zhu,
  • Jianzhong Deng,
  • Ying Shen,
  • Anqi Jiang,
  • Yixin Xu,
  • Jianhua Jin,
  • Yongzhong Hou,
  • Qian Liu

摘要

NKD1 is a known suppressor of the Wnt/β-catenin pathway. However, our previous study revealed that NKD1 could promote the proliferation and migration of colon cancer cells, enhancing colon cancer progression via unknown mechanisms. In the present study, we found that peroxisome proliferator-activated receptor δ (PPARδ) is a transcription factor of the NKD1 gene. By analyzing the differential protein expression profiles between SW620 and SW620-nkd1−/− cells, we found that NKD1 dramatically increased MYC protein expression. Further study revealed that the MYC protein was degraded mainly through the autophagy pathway in colon cancer cells and that NKD1 restrained this process by suppressing the interaction between LC3B and MYC proteins. Interestingly, we found that NKD1 inhibited the autophagy signaling pathway. In-depth research revealed that NKD1 bound to the MYC protein through the EF-hand domain, facilitating the entry of the MYC protein into the nucleus and inhibiting cell apoptosis. Moreover, NKD1 activated the expression of MYC downstream target genes through MYC. Functionally, the PPARδ/NKD1/MYC signaling pathway increased colon cancer cells’ proliferation, migration and angiogenesis capabilities. Therefore, NKD1 may serve as a specific biomarker for colon cancer and a potential new target for tumor treatment.